Thousands of men with incurable prostate cancer will be offered a lifeline after an about-turn on NHS treatment.

Thousands of men in England living with advanced prostate cancer are poised to benefit from a new life-extending drug, ...

CEDAR RAPIDS, Iowa — Mercy Medical Center has introduced a new non-invasive treatment for men with localized prostate cancer ...

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, ...

Mercy Medical Center is offering a new, noninvasive treatment option for men with localized prostate cancer using ...

An individual-patient meta-analysis sheds light on the optimal duration of androgen deprivation therapy in men with prostate cancer on definitive radiotherapy.

In this analysis, researchers aimed to evaluate the clinicopathologic characteristics, metastatic patterns, and survival outcomes in patients with metastatic prostate cancer and low-volume primary ...

Abiraterone will be available in a matter of weeks and will be offered to 7,000 men a year.

Ernie Strauss and Ronald Wakefield, who met through the patient navigation program of Northside Hospital, have built a ...

To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...

New recommendations prioritise multiparametric MRI, safer transperineal biopsy, and earlier escalation for high-risk prostate-specific antigen relapse.

The Kenyatta University Teaching, Referral and Research Hospital (KUTRRH) has made a major leap in cancer care, becoming the first public hospital in the region to offer Lutetium-177 PSMA therapy.